Cardiac Insight reported raising $7.1 million of a hoped-for $9.1 million round for its Stealth atrial fibrillation monitoring patch.
The equity round involved 2 unnamed investors, with the 1st sale coming June 26, according to a regulatory filing.
Cardiac Insight, a Bellevue, Wash.-based spinout from the University of Washington, won 510(k) clearance from the FDA for the Stealth device last year.
The device, developed for less than $2 million, is designed to be a platform for future devices, Cardiac Insight said at the time.
The filing reveals that Cardiac Insight’s board is stacked with big names in the world of cardiology, including Dr. Robert Hauser of Allina Hospitals & Clinics in the Twin Cities; former SonoSite chairman Kirby Cramer; ex-Physio-Control president Richard Martin; and former Pathway Medical Technologies founder & CEO Tom Clement.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.